Direktif untuk mengehadkan penggunaan produk yang mengandungi lovastatin dengan kontraindikasi dan had dos yang baru untuk mengurangkan risiko kecederaan otot
- Posted By LIM SZE GEE
- Hits: 15485
User Rating: 2 / 5
 |
 |
 |
 |
National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.
- Phone: +603-7883 5400
More Links
More Links
DISCLAIMER
The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.
Site Last Modified
- Last Modified: Friday 20 December 2024, 19:30:56.